Bayesian Capital Management’s Target TGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,248
Closed -$220K 213
2025
Q4
$220K Buy
+2,248
New +$207K 0.5% 77
2025
Q2
Sell
-36,263
Closed -$3.78M 872
2025
Q1
$3.78M Buy
36,263
+32,146
+781% +$4.02M 0.63% 31
2024
Q4
$557K Sell
4,117
-25,000
-86% -$3.58M 0.07% 347
2024
Q3
$4.54M Buy
+29,117
New +$4.34M 0.53% 32
2024
Q2
Sell
-21,917
Closed -$3.88M 1090
2024
Q1
$3.88M Sell
21,917
-39,583
-64% -$6.02M 0.37% 64
2023
Q4
$8.76M Buy
61,500
+16,400
+36% +$2M 0.93% 12
2023
Q3
$4.99M Buy
+45,100
New +$5.73M 0.57% 36
2022
Q4
Sell
-22,923
Closed -$3.4M 1029
2022
Q3
$3.4M Buy
+22,923
New +$3.67M 0.69% 17
2022
Q2
Sell
-15,400
Closed -$3.27M 1075
2022
Q1
$3.27M Buy
+15,400
New +$3.33M 0.49% 28
2021
Q4
Sell
-8,194
Closed -$1.88M 512
2021
Q3
$1.88M Buy
+8,194
New +$2.05M 0.54% 40
2021
Q1
Sell
-4,300
Closed -$759K 685
2020
Q4
$759K Buy
+4,300
New +$717K 0.2% 150
2020
Q3
Sell
-42,900
Closed -$5.14M 692
2020
Q2
$5.14M Buy
42,900
+13,976
+48% +$1.6M 1.13% 6
2020
Q1
$2.69M Sell
28,924
-59,800
-67% -$6.64M 0.58% 19
2019
Q4
$11.4M Buy
88,724
+200
+0.2% +$23.5K 1.94% 2
2019
Q3
$9.46M Sell
88,524
-900
-1% -$85.6K 1.79% 4
2019
Q2
$7.75M Buy
+89,424
New +$7.23M 1.6% 2
2019
Q1
Sell
-31,500
Closed -$2.08M 744
2018
Q4
$2.08M Buy
+31,500
New +$2.42M 0.43% 43
2017
Q4
Sell
-11,300
Closed -$667K 725
2017
Q3
$667K Sell
11,300
-6,700
-37% -$375K 0.16% 207
2017
Q2
$941K Buy
+18,000
New +$983K 0.35% 85
2017
Q1
Sell
-37,700
Closed -$2.72M 682
2016
Q4
$2.72M Buy
+37,700
New +$2.73M 0.68% 3

Other funds holding TGT

Bayesian Capital Management's TGT Position: Q1 2026 in Review

Bayesian Capital Management sold out of Target (TGT) in Q1 2026, closing a stake of 2,248 shares — an estimated $220K sold.

Bayesian Capital Management first reported a position in TGT in Q4 2016 and held it in 20 quarters. The position peaked at $11.4M in Q4 2019. 1,842 funds tracked by Wall St. Rank hold TGT as of Q1 2026.

  • Bayesian Capital Management reported no remaining Target position as of Q1 2026 after selling out during the quarter.
  • Bayesian Capital Management sold 2,248 Target shares in Q1 2026, an estimated $220K.
  • Bayesian Capital Management first reported a position in Target in Q4 2016 and held it in 20 quarters.
  • Bayesian Capital Management's Target position peaked at $11.4M in Q4 2019.
  • 1,842 funds tracked by Wall St. Rank held Target as of Q1 2026.

Based on Bayesian Capital Management's 13F filing for Q1 2026, filed 15 May 2026.